RNF139 serves as a tumor-suppressor in glioma by inhibiting cancer cell proliferation, migration, and invasion and promoting cancer cell apoptosis through regulating PI3K/AKT signaling. This evidence concerns the gene RNF139 and central nervous system cancer.